Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$40.97 - $43.33 $228,899 - $242,084
-5,587 Reduced 15.14%
31,317 $1.33 Million
Q4 2023

Feb 09, 2024

SELL
$32.77 - $42.31 $565,970 - $730,736
-17,271 Reduced 31.88%
36,904 $1.54 Million
Q3 2023

Nov 09, 2023

BUY
$35.46 - $40.13 $694,590 - $786,066
19,588 Added 56.63%
54,175 $2.04 Million
Q2 2023

Aug 11, 2023

BUY
$24.24 - $40.97 $815,797 - $1.38 Million
33,655 Added 3611.05%
34,587 $1.31 Million
Q1 2023

May 12, 2023

BUY
$23.0 - $31.59 $8,763 - $12,035
381 Added 69.15%
932 $22,000
Q4 2022

Feb 08, 2023

BUY
$27.6 - $32.99 $12,447 - $14,878
451 Added 451.0%
551 $16,000
Q3 2022

Nov 10, 2022

SELL
$28.74 - $39.9 $23,710 - $32,917
-825 Reduced 89.19%
100 $3,000
Q2 2022

Aug 10, 2022

BUY
$35.0 - $43.59 $13,510 - $16,825
386 Added 71.61%
925 $34,000
Q1 2022

May 16, 2022

SELL
$43.12 - $50.3 $10,176 - $11,870
-236 Reduced 30.45%
539 $24,000
Q4 2021

Feb 14, 2022

BUY
$47.6 - $65.0 $13,280 - $18,135
279 Added 56.25%
775 $39,000
Q3 2021

Nov 15, 2021

SELL
$62.34 - $73.38 $257,775 - $303,426
-4,135 Reduced 89.29%
496 $32,000
Q2 2021

Aug 13, 2021

SELL
$70.26 - $76.64 $53,467 - $58,323
-761 Reduced 14.11%
4,631 $333,000
Q1 2021

May 12, 2021

SELL
$70.48 - $79.95 $26,993 - $30,620
-383 Reduced 6.63%
5,392 $398,000
Q4 2020

Feb 11, 2021

SELL
$54.4 - $73.42 $3.39 Million - $4.58 Million
-62,385 Reduced 91.53%
5,775 $424,000
Q3 2020

Nov 12, 2020

BUY
$54.41 - $68.2 $1.18 Million - $1.48 Million
21,655 Added 46.56%
68,160 $3.74 Million
Q2 2020

Jul 31, 2020

BUY
$61.66 - $70.16 $2.63 Million - $2.99 Million
42,585 Added 1086.35%
46,505 $3.09 Million
Q1 2020

May 01, 2020

BUY
$59.35 - $88.73 $80,122 - $119,785
1,350 Added 52.53%
3,920 $240,000
Q4 2019

Feb 14, 2020

SELL
$74.18 - $97.92 $164,308 - $216,892
-2,215 Reduced 46.29%
2,570 $226,000
Q3 2019

Nov 14, 2019

SELL
$75.36 - $86.57 $588,034 - $675,505
-7,803 Reduced 61.99%
4,785 $361,000
Q2 2019

Aug 14, 2019

BUY
$83.92 - $108.88 $905,832 - $1.18 Million
10,794 Added 601.67%
12,588 $1.08 Million
Q1 2019

May 14, 2019

BUY
$85.97 - $108.09 $17,451 - $21,942
203 Added 12.76%
1,794 $194,000
Q4 2018

Feb 14, 2019

BUY
$78.25 - $107.92 $50,314 - $69,392
643 Added 67.83%
1,591 $135,000
Q3 2018

Nov 14, 2018

SELL
$97.82 - $116.09 $94,885 - $112,607
-970 Reduced 50.57%
948 $94,000
Q2 2018

Aug 14, 2018

SELL
$97.62 - $120.59 $391,260 - $483,324
-4,008 Reduced 67.63%
1,918 $222,000
Q1 2018

May 15, 2018

SELL
$95.91 - $107.26 $26,471 - $29,603
-276 Reduced 4.45%
5,926 $585,000
Q4 2017

Feb 14, 2018

SELL
$104.5 - $126.38 $283,717 - $343,121
-2,715 Reduced 30.45%
6,202 $650,000
Q3 2017

Nov 14, 2017

BUY
$97.26 - $116.2 $189,948 - $226,938
1,953 Added 28.04%
8,917 $1.01 Million
Q2 2017

Aug 14, 2017

SELL
N/A
-11,653 Reduced 62.59%
6,964 $780,000
Q1 2017

Nov 14, 2017

BUY
N/A
18,617
18,617 $2.17 Million

Others Institutions Holding TARO

About TARO PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TARO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 37,584,600
  • Description
  • Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage...
More about TARO
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.